Source file signed link, expires in 15 minutes
Extracted text 1
Page 1 OCR 0.937
| PT IKAPHARMINDO PUTRAMAS Tbk Pharmaceutical Laboratories Jl. Pulogadung Raya No. 29, Kawasan Industri Pulogadung, Jakarta Timur 13930 - Indonesia Phone : #62 21 460 0086/461 4766 (Hunting), Fax : #62 21 460 8865 Email : secretary@ikapharmindo.com, website : www.ikapharmindo.com No.: 27/DIR/IV/25 Jakarta, 21 April 2025 Kepada Yth.: PT Bursa Efek Indonesia Gedung Bursa Efek Indonesia, Tower 1, Lantai 6 Jl. Jend. Sudirman Kav 52-53 Jakarta Selatan 12190, Indonesia Up.: Dewan Direksi Perihal: Penyampaian Materi Public Expose Tahunan PT Ikapharmindo Putramas Tbk Dengan hormat, Dalam rangka memenuhi ketentuan Perubahan Peraturan Nomor I-E Tentang Kewajiban Penyampaian Informasi ketentuan poin III.3, Lampiran Keputusan Direksi PT Bursa Efek Indonesia No. Kep-00066/BEI/09-2022 tanggal 30 September 2022, bersama ini kami sampaikan Materi Public Expose Tahunan PT Ikapharmindo Putramas Tbk (“Perseroan”). Demikian Penyampaian Materi Public Expose Tahunan Perseroan ini kami sampaikan, atas perhatian dan kerja sama yang baik kami ucapkan terima kasih. Hormat kami, PT Ikapharmindo Putramas Tbk & PHARMINDO PUTRAMAS Tbk PHARMACEUTICAL LABORATORIES Karti Direktur Utama £
Names mentioned 4 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PHARMINDO PUTRAMAS Tbk
p.1
unresolved
person
Karti
· Direktur Utama £
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.